Dgl Group Limited · ASX:DGL
Dgl — H1 FY2022 Earnings Presentation
16 slides from Dgl's earnings presentation, Feb 25, 2022
Slide 1: 1H FY22 Results Presentation
1H FY22 RESULTS PRESENTATION 25 February 2022 Presented by: Simon Henry, CEO
Slide 2: Important Notice and Disclaimer
Important Notice and Disclaimer NO RELIANCE FORWARD LOOKING STATEMENTS The information contained in this document is not investment or financial This document contains certain forward looking statements and comments product advice and is not intended to be relied upon as the basis for an about futur
Slide 3: Introduction to DGL
Introduction to DGL A SPECIALTY CHEMICALS AND SUPPLY CHAIN BUSINESS OFFERING A FULL-SERVICE SOLUTION FROM MANUFACTURE TO RECYCLE ACROSS AUSTRALIA AND NEW ZEALAND $343m $417m FY22 forecast sales Total Assets at revenue guidance December 21 486 54 Staff - Aust. & NZ Sites across Formulation and Collec
Slide 4: 1H FY22 Highlights
1H FY22 Highlights ACQUISITIONS AND ORGANIC GROWTH HAVE LED TO MATERIAL INCREASE IN DGL GROUP SCALE OVER THE LAST 6 MONTHS Employees Active Customers (pro-forma)1 486 3005 HIGHLIGHTS • More than 480 employees across the Group at December 2021, up from 290 at June 21 290 • Active customers increased
Slide 5: 1H FY22 Financial Highlights
1H FY22 Financial Highlights STRONG PERFORMANCE, EXCEEDED THE PRIOR COMPARABLE PERIOD, ACQUISITIONS SUCCESSFULLY INTEGRATED DURING FIRST HALF REVENUE EBITDA HIGHLIGHTS $143M $20.6M 7 acquisitions (total cash investment of $41m) successfully integrated during first half up 55% on pro-forma PCP2 up 59
Slide 6: Financials
| FINANCIALS
Slide 7: Group Performance (Statutory Results)
Group Performance (Statutory Results) Statutory Results 1H FY22 1H FY21 % variance COMMENTARY 6mths ended 31 Dec 21 (A$m) Sales revenue 143.0 50.7 182% • Strong performance across all segments during the first half of FY22 Cost of sales (89.6) (26.9) Gross profit 53.5 23.7 125% • Growth of underlyin
Slide 8: Group Performance
Group Performance STRONG HALF-ON-HALF GROWTH CONTINUES – WELL SUPPORTED BY ORGANIC GROWTH AND DIVERSIFIED REVENUE STREAMS Sales Revenue (A$m) FY21: 197 Pro-forma Customer Concentration3 Revenue by Industry4 6 months ended 31 Dec 2021 6 months ended 31 Dec 2021 Water 5% Cust. 1 2H 143 10% 104 Acquisi
Slide 9: Balance Sheet
Balance Sheet (A$m) 31 DEC 2021 30 JUNE 2021 Cash and cash equivalents 16.1 43.8 COMMENTARY Trade and other receivables 50.5 22.5 • Considerable growth in Group assets, funded by earnings, debt Inventories 32.1 14.4 Other financial assets 1.5 1.6 and scrip issued to vendors of acquired businesses. T
Slide 10: Cash Flows
Cash Flows Statutory Results 1H FY22 1H FY21 COMMENTARY 6mths ended 31 Dec 21 (A$m) CASH FLOWS FROM OPERATING ACTIVITIES • Growing operating cash flow (compared to 1H FY21) benefiting from 1H earnings growth Receipts from customers 118.7 52.2 Payments to suppliers and employees (101.9) (43.7) • Incr
Slide 11: Strategy Update
| STRATEGY UPDATE
Slide 12: 1H FY22 Progress
FY22 Strategy Progress Substantial progress across all key areas of focus OUR OBJECTIVE To be Australasia's leading fully integrated, end-to-end chemicals business STRATEGIC PRIORITIES Drive Cross-Selling Achieve Further Investment in Identify Between Segments Economies of Scale Capital Projects Acq
Slide 13: Property and Projects
Property and Projects CONTINUED FOCUS ON OWNED STRATEGIC PROPERTY TO PROVIDE FLEXIBILITY AND SECURITY Value of Owned Property Portfolio (A$m) COMMENTARY 140 • 18 properties owned at Dec 21 valued at $118m, up $23m on June 21 (Jun 21: $95m). Additional property committed to in 120 Feb 22, lifting por
Slide 14: Quality, Health & Safety
Quality, Health & Safety COMPLIANCE, PROCEDURES AND TRAINING UNDERPIN OUR APPROACH TO H&S AND QUALITY Extensive Licences and Accreditations • Portfolio of licences, developed over 20+ years WHSE Director • Underpins safety in operations, and environmental and quality standards. Health and Environmen
Slide 15: Outlook and Summary
Outlook and Summary FOCUSED ON DELIVERING GROWTH FOR OUR SHAREHOLDERS Sales Revenue COMMENTARY (A$m) • Full year FY22 forecasts upgraded, significantly better than 343 Prospectus forecasts - FY22 revenue forecast guidance at $343m - FY22 EBITDA forecast guidance at $54m (before acquisition costs), 2
Slide 16: Appendix
Appendix PRO-FORMA RESULTS AS PRESENTED IN THE IPO PROSPECTUS AND PREVIOUS RESULTS ANNOUNCEMENTS FY19, FY20, 1H FY21 include Chem Pack contribution on a pro-forma basis as detailed in the IPO Prospectus and previous DGL announcements. Summarised in the table below. Summary Pro-forma Summary Pro-form